SOXX is having a week that puts short sellers in an uncomfortable spot — a 14.8% gain in five sessions while short interest holds near 22.5% of float is the clearest tension in the positioning data right now.
The price action is striking. SOXX closed at $572.78 on Tuesday, up 2.4% on the day and 14.8% on the week. The monthly gain of just over 10% suggests this isn't a one-day event — the ETF has been grinding higher since late August. For a fund carrying more than 22% of its float short, that kind of sustained move creates compounding pain for anyone holding a negative position.
The positioning story, however, is not as straightforward as a simple short squeeze. Short interest did trim about 2% over the past week, falling from roughly 12.8 million shares to 12.7 million — but it remains well above the levels of mid-August, when the borrow pool was far tighter. What changed dramatically is availability: after running fully extended through most of September — with availability reading as low as 4.3% at its tightest point in mid-August — the lending pool has loosened considerably. Availability has rebounded to 154%, meaning there are now roughly 1.5 shares available for every one already borrowed. That compares to a streak of nine consecutive sessions ending September 17 where availability was below 55% and the borrow pool was fully maxed. Cost to borrow, which touched 1.86% on September 15, has also eased back to just under 1% — down nearly 47% over the week. The borrow market is no longer in crisis mode. That loosening matters: new shorts can now be established at a fraction of the cost they faced two weeks ago, which may explain why short interest hasn't collapsed despite the rally.
Options traders are moving in the other direction from the borrow market. The put/call ratio has spiked to 1.49 — more than 2.6 standard deviations above its 20-day average of 1.29 — making this one of the more defensively positioned readings of the past year. The ratio hit an extreme of 4.28 on August 24 during the worst of the selloff, then retreated to its recent average through early September. The renewed push higher in the PCR this week, running against a rising price trend, points to a cohort of investors buying downside protection even as the ETF rallies. Whether that reflects hedging by long holders or outright bearish bets is hard to disentangle, but the direction is clear: options activity has turned notably more cautious precisely when the price is making new near-term highs.
The institutional register adds texture to the flow picture. Goldman Sachs held the largest disclosed stake as of June 30 at 5.85% of shares, adding 213,000 shares over the quarter. More notable are the concentrated additions from Susquehanna International Group, which added 877,000 shares over the same period — a jump significant enough to push it to the second-largest position in the fund. Healthcare of Ontario Pension Plan and Holocene Advisors each effectively opened new positions, adding 640,000 and 760,000 shares respectively. These are Q2 snapshots and don't capture what happened during the August and September volatility, but the direction of travel through the first half of the year was clearly net accumulative from institutional buyers. Morgan Stanley, by contrast, trimmed 356,000 shares over the quarter — one of the larger reductions in the holder list.
SOXX's ORTEX short score — a composite signal drawing on the full range of short-side data — has held in a tight band around 67 for the past two weeks, with no material directional move despite the sharp price recovery. That stability is in itself a signal: even as the stock rallied hard, the short-positioning complex didn't unwind in a way that dramatically changed the overall scoring. The score peaked at 67.4 on September 15 when the borrow market was at its tightest and availability was near its lows. It has edged slightly lower but remains elevated, consistent with a market that is watching the rally but not abandoning the short thesis.
The key variable to watch is whether the borrow market tightens again. Availability has moved from fully constrained to comfortable in less than a week, largely tracking the sharp price recovery. If the chip rally stalls and the price pulls back, the question is whether the institutional buyers who added aggressively in Q2 hold their ground — or whether the 22%-plus short interest, now much cheaper to maintain at sub-1% cost to borrow, reasserts itself.
See the live data behind this article on ORTEX.
Open SOXX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
